Pfizer

Market Cap (₹ Cr.)

₹23,718

52 Week High

6,451.15

Book Value

₹

52 Week Low

3,950.00

PE Ratio

38.75

PB Ratio

6.32

PE for Sector

47.51

PB for Sector

85.19

ROE

15.33 %

ROCE

20.68 %

Dividend Yield

0.68 %

EPS

₹131.73

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Multinational

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

-6.02 %

Net Income Growth

-11.64 %

Cash Flow Change

-27.79 %

ROE

-21.18 %

ROCE

-8.06 %

EBITDA Margin (Avg.)

-4.60 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Revenue	482	500	537	506	541	531	663	537	467	448	595	489	551	543	557	578	571	580	612	596	547	532	608	608	572	761	651	694	567	611	851	649	604	565	611	584	622	605	632
Expenses	338	370	396	425	390	400	444	429	343	344	404	339	381	382	390	359	385	378	403	405	393	329	392	397	409	463	447	481	384	537	406	418	410	421	393	387	357	385	399
EBITDA	144	130	142	81	151	131	219	108	123	104	191	150	170	161	167	219	186	202	209	192	154	203	215	211	163	298	204	213	183	74	445	231	194	144	219	196	265	219	232
Operating Profit %	26 %	23 %	22 %	15 %	24 %	20 %	17 %	13 %	22 %	18 %	29 %	26 %	27 %	25 %	25 %	30 %	28 %	31 %	29 %	25 %	22 %	36 %	34 %	33 %	24 %	38 %	30 %	29 %	30 %	9 %	36 %	33 %	28 %	21 %	32 %	28 %	35 %	32 %	32 %
Depreciation	34	15	13	15	15	15	16	15	16	15	16	18	17	18	18	18	18	25	25	25	28	27	28	27	27	27	27	27	34	27	26	26	26	16	15	18	14	15	15
Interest	0	0	0	0	0	0	0	0	0	0	0	0	-0	0	0	0	1	2	3	2	4	3	5	4	4	2	2	2	4	4	3	4	3	3	3	3	7	2	2
Profit Before Tax	110	116	129	65	136	115	203	92	107	89	175	132	153	142	149	201	168	175	181	165	122	173	183	180	132	269	175	184	145	43	415	201	165	126	201	176	244	203	215
Tax	67	40	46	30	63	38	82	38	30	33	74	48	39	53	58	72	61	71	33	42	-12	50	57	38	39	71	42	55	29	26	107	52	67	33	47	29	49	55	60
Net Profit	43	75	83	60	87	80	126	62	68	57	111	87	105	92	96	132	109	113	154	139	103	124	131	141	101	200	143	144	126	33	311	151	130	94	149	130	179	151	158
EPS in ₹	9.33	16.43	18.11	13.06	19.06	17.50	27.61	13.63	14.87	12.50	24.29	19.07	22.84	20.07	20.94	28.84	23.93	24.66	33.72	30.40	22.52	27.20	28.71	30.87	21.98	43.69	31.25	31.46	27.50	7.11	67.99	32.93	30.03	20.44	32.56	28.42	39.09	32.94	34.61

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	2,612	2,914	3,261	3,690	3,940	4,405	3,266	3,901	4,001	4,229
Fixed Assets	944	895	902	950	886	973	894	869	749	713
Current Assets	1,253	1,630	2,051	2,417	2,715	3,048	1,925	2,396	2,493	2,738
Capital Work in Progress	13	3	15	1	0	1	3	1	8	0
Investments	0	4	0	0	0	0	0	0	0	0
Other Assets	1,655	2,011	2,343	2,739	3,054	3,432	2,369	3,030	3,244	3,516
Total Liabilities	639	796	842	1,007	929	1,010	873	1,036	793	633
Current Liabilities	606	759	780	954	892	873	774	853	657	547
Non Current Liabilities	32	36	62	52	37	137	99	183	136	87
Total Equity	1,973	2,118	2,419	2,683	3,011	3,395	2,393	2,864	3,207	3,596
Reserve & Surplus	1,927	2,072	2,373	2,637	2,966	3,350	2,347	2,819	3,162	3,550
Share Capital	46	46	46	46	46	46	46	46	46	46

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	181	-417	-3	-17	23	1,690	-1,613	-88	-26	75
Investing Activities	68	-701	-250	-238	35	1,530	-469	-575	-36	54
Operating Activities	113	345	329	332	98	323	427	667	356	257
Financing Activities	-1	-62	-83	-110	-110	-164	-1,571	-181	-346	-235

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Promoter	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %	63.92 %
FIIs	1.89 %	2.07 %	2.07 %	2.13 %	2.20 %	2.55 %	2.55 %	2.77 %	2.80 %	2.81 %	2.82 %	3.03 %	3.32 %	3.22 %	3.54 %
DIIs	14.63 %	15.14 %	15.14 %	15.02 %	15.06 %	14.83 %	14.88 %	14.93 %	14.90 %	14.89 %	15.01 %	15.15 %	15.33 %	15.84 %	16.04 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	19.55 %	18.86 %	18.86 %	18.92 %	18.82 %	18.70 %	18.65 %	18.38 %	18.38 %	18.37 %	18.25 %	17.90 %	17.42 %	17.01 %	16.50 %

Show % Change

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Abbott	27,034.10	57,786.83	44.98	6,097.18	10.80	1,201	14.59	34.34
GlaxoSmithKline Pharmaceuticals	2,388.00	41,271.55	51.47	3,576.30	6.68	590	16.09	34.50
Pfizer	5,124.80	23,718.14	38.75	2,373.68	-6.02	551	6.30	38.21
AstraZeneca Pharma	6,343.10	16,243.75	126.19	1,330.33	29.27	162	-26.62	33.77
Sanofi	6,114.40	14,161.03	33.59	2,916.40	-	603	-45.89	32.33
Sanofi Consumer Healthcare	4,789.10	11,103.98	-	0.00	-	0	-36.80	47.04
Procter & Gamble Health	5,085.85	8,524.02	37.61	1,166.89	-6.50	201	25.56	43.78